Pioglitazone, an in vitro inhibitor of CYP2C8 and CYP3A4, does not increase the plasma concentrations of the CYP2C8 and CYP3A4 substrate repaglinide (Q46919666)
Jump to navigation
Jump to search
scientific article published on 31 January 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pioglitazone, an in vitro inhibitor of CYP2C8 and CYP3A4, does not increase the plasma concentrations of the CYP2C8 and CYP3A4 substrate repaglinide |
scientific article published on 31 January 2006 |
Statements
1 reference
Pioglitazone, an in vitro inhibitor of CYP2C8 and CYP3A4, does not increase the plasma concentrations of the CYP2C8 and CYP3A4 substrate repaglinide (English)
1 reference
1 reference
Lauri I Kajosaari
1 reference
Tiina Jaakkola
1 reference
31 January 2006
1 reference
62
1 reference
3
1 reference
217-223
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference